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N-lobe versus C-lobe complexation of bismuth by human transferrin
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Interactions of recombinant N-lobe of human serum transferrin
(hTF2N) with Bi+, a metal ion widely used in medicine, have
been investigated by both UV and NMR spectroscopy. The
bicarbonate-independent stability constant for Bi+ binding (K*)
to hTF2N was determined to be log K* 18.90.2 in 5 mM
bicarbonate10 mMHepes buffer at 310 K, pH 7.4. The presence
of Fe+ in the C-lobe of intact hTF perturbed Bi+ binding to the
N-lobe, whereas binding of Bi+ to the C-lobe was unaffected by
the presence of Fe+ in the N-lobe. Reactions of Bi+ (as bismuth
nitrilotriacetate or ranitidine bismuth citrate) with hTF2N in
INTRODUCTION
Transferrin belongs to a class of 80 kDa monomeric glycopro-
teins, which are functional in iron transport and detoxification in
vertebrates [1,2]. It has two structurally similar lobes, each of
approx. 40 kDa, linked by a short peptide and each lobe contains
an interdomain high-affinity metal-binding site [3,4]. The X-ray
crystal structures of rabbit serum transferrin [5,6], the related
protein diferric lactoferrin [7,8] and monoferric human trans-
ferrin [9] show that Fe+ in each lobe has approx. octahedral co-
ordination, consisting of two oxygens from two tyrosine side-
chains, one nitrogen from histidine, one oxygen from aspartate
and two oxygens from a bidentate synergistic anion, carbonate.
An important feature that has emerged from X-ray studies of
transferrin and lactoferrin is that iron induces a conformational
change from a lobe-open (apo-form) to a lobe-closed (holo-
form). Only the holo-form (metal loaded in both lobes), and not
the apo-form, binds strongly to the cell receptor and is taken up.
Many other metal ions can bind in the Fe+ site [10]. Recently we
found that Bi+, a large metal ion of ionic radius 1.03 A
(0.103 nm), which is widely used in medicine in anti-bacterial
and anti-ulcer drugs [11,12], binds to human serum transferrin
(hTF) strongly with bicarbonate-independent stability constants
(K*) of log K*

and log K*

 19.4 and 18.6 respectively (in
10 mM Hepes buffer5 mM bicarbonate at 310 K, pH 7.4) [13].
We were subsequently able to correlate strength of binding of a
wide range of metal ions to transferrin with metal acidity (log
K
OH
) [14,15]. This binding ability is of potential importance for
the transport and delivery of bismuth-containing drugs and
control of bismuth levels in the body, since the distribution of
bismuth in blood plasma and other biofluids is still not well
understood.
Previously we have shown that there is preferential binding of
Bi+ to the C-lobe of hTF with bicarbonate as the synergistic
Abbreviations used: hTF, human serum transferrin ; hTF/2N, recombinant N-lobe of hTF; FeN/C-hTF, monoferric transferrin with Fe
3+ in the N- or C-
lobe; K*, bicarbonate-independent stability binding constant ; NTA, nitrilotriacetate ; pH*, pH meter reading for 2H2O solution; RBC, ranitidine bismuth
citrate.
1 To whom correspondence should be addressed (e-mail p.j.sadlered.ac.uk).
solutions containing 10 mMbicarbonate induced specific changes
to high-field H-NMRpeaks. The Hco-ordination shifts induced
byBi+were similar to those induced byFe+ andGa+, suggesting
that Bi+ binding causes similar structural changes to those
induced by hTF2N. C-NMR data showed that carbonate
binds to hTF2N concomitantly with Bi+.
Key words: metal binding, NMR spectroscopy, protein con-
formation, stability constant, serum protein.
anion [13]. There is currently much interest in the functional
difference between the two lobes of transferrin. In blood,
transferrin is only about 30% saturated with Fe+, and this is
thought to occupy the N-lobe [16]. To investigate possible inter-
lobe interactions, we have now determined the stability constant
for Bi+ binding to the recombinant N-lobe of hTF (hTF2N)
and compared it with that for Bi+ binding to intact hTF,
with Fe+ occupying either the N- or the C-lobe. We have
also investigated Bi+-induced structural changes by NMR
spectroscopy.
EXPERIMENTAL
Materials
Apo-hTF was purchased from Sigma (catalogue no: T0519).
hTF2N was expressed in the methylotrophic yeast, Pichia
pastoris, by placing the hTF2N cDNA under the control of the
methanol-inducible alcohol oxidase promoter, and purified as
described previously [17]. The Fe+ was removed by additions of
metal-removal buffer [1 mM nitrilotriacetate (NTA)1 mM
EDTA0.5 M sodium acetate (pH 4.9)] [18], followed by ultra-
filtration three times (1 h each time) in a Centricon 10 (Amicon,
Stonehouse, Gloucestershire, U.K.). Finally, the protein was
washed four times with 0.1 M KCl to remove low-molecular-
mass impurities via ultrafiltration (Centricon 10). For apo-hTF,
a similar procedure was used to remove low-molecular-mass
impurities (Centricon 30). Monoferric transferrins (selective
loading of Fe+ in either the N- or C-lobe of transferrin) were
prepared as described previously [19]. Use of the reported
procedure for selective Fe+ loading of the N-lobe [using
Fe(NH

)

(SO

)

] appears to provide  80% selective N-lobe
loading [20], although in NMR experiments we have found that
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the selectivity is slightly lower [21]. Crystalline Bi-NTA was
synthesized using a procedure in the literature [22] and had a
satisfactory elemental analysis. Ranitidine bismuth citrate (RBC)
was supplied by Glaxo Wellcome (Stevenage, Herts., U.K.).
NaHCO

, KCl, H

NTA and Hepes were purchased fromAldrich
(Milwaukee, WI, U.S.A) and NaHCO

(99% enriched-C)
was from MSD Isotopes (Montreal, Canada).
Preparation of NMR samples
To allow H–H exchange, apo-hTF2N was dissolved in 0.1 M
KCl in H

O, and after adjustment of the pH* (pHmeter reading
for H

O solution) to 7.8, this was left for 4 h at ambient
temperature. After freeze-drying, the sample was redissolved in
H

O containing 10 mMNaHCO

. The pH* was then readjusted
to 7.800.05, when necessary, using NaOH and HCl (0.2 M).
The pH* values of NMR solutions were recorded before and
after NMR measurements.
Samples for electronic absorption spectroscopy
These were prepared by diluting aliquots of stock apo-hTF2N
or monoferric transferrin solutions to approx. 10− M with
10 mM Hepes buffer, pH 7.4. The concentrations were deter-
mined spectrophotometrically on the basis of ε

38600 and
103000 M−cm− for hTF2N and monoferric transferrins re-
spectively [17,23]. Immediately before addition of Bi+, an aliquot
of a concentrated solution of NaHCO

(0.25 M) was added to
give 5 mM HCO

−. The spectrum of the apo-hTF2N solution
(containing 5 mM bicarbonate) was recorded after equilibration
at 310 K for 10 min. Aliquots of the stock solution of bismuth
(usually 5–20 μl of Bi-NTA solution) were then added to the
apo-hTF2N cuvette and spectra were recorded after at least
0.5 h equilibration at 310 K. A similar procedure was used for
titration of monoferric transferrins with Bi-NTA.
NMR spectroscopy
H-NMR spectra were recorded on Bruker DMX 500 or Varian
Unity 600 spectrometers at 500 and 600 MHz respectively.
Spectra were acquired using 0.7 ml of solution in 5-mm tubes
(0.9 mM hTF2N) at 310 K, and 400–1200 transients, 6 μs (50)
pulses, recycle time of 2 s, 16 Kdata points andwater suppression
via pre-saturation. The chemical shift reference compound was
dioxane via endogenous formate (8.465 p.p.m., pH* 7), which
was always present in our samples as a minor impurity. Res-
olution enhancement of the spectra was achieved by processing
the free induction decays with a combination of unshifted sine-
bell and exponential functions (line broadening of 1.5–5 Hz) on
a Silicon Graphics computer using Varian VNMR software
(VNMR, 4.3) and Xwin NMR (2.0). Two-dimensional TOCSY
and NOESY spectra (mixing times 60 and 50 ms respectively) of
hTF2N at pH* 7.25 were acquired using 2 K data points in the
f2 dimension, acquisition time 0.12 s, 48 scans and 256 increments
in the f1 dimension, in a total time of 14 h. Unshifted Gaussian
functions were used in both dimensions for processing two-
dimensional spectra.
The H-decoupled C spectrum was recorded at 310 K on the
Bruker DMX 500 MHz NMR spectrometer equipped with a
5-mm broad-band probe at a resonance frequency 125 MHz.
Typically 20000–40000 transients were collected using a pulse-
width of 8 μs (50), a relaxation delay of 2 s and 16 K data
points. The spectra were processed using an exponential function
(8–10 Hz) before Fourier transformation.
RESULTS
Electronic absorption spectroscopy
The complexation of metal ions to the phenolate groups of
the tyrosine residues in the specific metal-binding sites of apo-
transferrin led to the production of two new absorption bands at
241 and 295 nm [2]. These new bands are readily apparent in
difference UV spectra of metal-containing transferrin and apo-
hTF.
The recombinant N-lobe of transferrin (hTF2N) was titrated
with Bi-NTAχ (χ 1,10), and the absorbance at 241 nm was
monitored. The UV difference spectra and titration curves are
shown in Figures 1 and 2 respectively. For the NTA:Bi 1: 1
curve, Δε increases linearly with an increase in the ratio of
Bi :hTF2N, and from the initial slope of the curve the molar
absorption coefficient of Bi-hTF2N was obtained as
22000 M−cm−. Owing to NTA competition, the titration curve
for NTA:Bi 10:1 levelled off, and Bi+ was loaded only
partially into the metal-binding site of hTF2N. This curve was
used to calculate the stability constant of Bi-hTF2N.
The stability constant determination was on the basis of the
competition reaction of NTA and hTF2N with Bi+, and
the following equations were used:
Bi-NTAhTF2NBi-hTF2NNTA
K
a
 [Bi-hTF2N][NTA][Bi-NTA][hTF2N] (1)
Bi+hTF2NBi-hTF2N
K [Bi-hTF2N][Bi+][hTF2N]K
Bi-NTA
K
a
(2)
K
a
was obtained from the Hill plot :
1Y 11K
a
[NTA][Bi-NTA] (3)
where Y [Bi-hTF2N][hTF2N]
total
, and the concentration of
Bi-hTF2N was calculated by assuming that full loading of
Figure 1 UV difference spectra for Bi 3+ binding to hTF/2N
Bi-NTA (0.2, 0.4, 0.6, 0.8, 1.0 and 1.4 molar equivalents) was added to 1.0910−5 M
recombinant hTF/2N in 10 mM Hepes buffer containing 5 mM bicarbonate, at 310 K, pH 7.4.
The two absorption bands at 241 and 295 nm are indicative of Bi3+ binding to the specific
binding site of hTF/2N.
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Figure 2 Titration curves for Bi 3+ binding to recombinant hTF/2N
Bi-NTAχ (where χ 1 and 10) was added to 1.0910−
5 M recombinant hTF/2N in 10 mM
Hepes buffer containing 5 mM bicarbonate at pH 7.4. Δε equals the absorbance at 241 nm
divided by the transferrin concentration. The insert is based on the titration of Bi-NTA10 with
hTF/2N, and allows determination of log Ka 1.40 ; R 0.997.
hTF2N with Bi+ gives a molar absorption coefficient of
22000 M−cm−. By plotting 1Y versus [NTA][Bi-NTA] (Fig-
ure 2 insert), log K
a
was obtained from the slope as 1.400.2.
The reported (log) stability constant of Bi-NTA is 17.75 [24],
therefore the stability constant of Bi-hTF2N is log K
19.150.2 (in 10 mM Hepes and 5 mM bicarbonate at 310 K,
pH 7.4). The bicarbonate-independent binding constant (log K*)
can be calculated to be 18.90.2 using the procedure reported
previously [25].
The effect of bound Fe+ on the uptake of Bi+ into either the
N- or C-lobe of intact hTF was studied. Apotransferrin was
selectively loaded with Fe+ in the C- or N- lobe and then titrated
with Bi+. The results are shown in Figure 3. When Bi+ (as Bi-
NTA) binds to the vacant C-terminal site of monoferric trans-
ferrin with Fe+ in the N-lobe (Fe
N
-hTF), the initial slope of the
curve (Δε 21740 M−cm−) is close to that observed for apo-
transferrin (Δε 21900 M−cm−) [13]. In contrast, binding of
Bi+ to the vacant N-terminal site of monoferric transferrin with
Fe+ in the C lobe (Fe
C
-hTF) gave amuch lowermolar absorption
coefficient of 12600 M−cm−. For hTF2N, the titration curve
is almost identical with that of N-terminal monoferric transferrin
(Fe
N
-hTF) with a molar absorption coefficient of
22000 M−cm−.
Ligand competition
Competition between hTF2N and citrate for Bi+ binding was
investigated. Large excesses of citrate removed Bi+ from the
binding site. The Δε value appeared to decrease almost linearly
with increase of citrate concentration (Figure 4). From the linear
range, it was calculated that an approx. 125-fold molar excess of
Figure 3 Titration curves for Bi 3+ binding to monoferric transferrins
Bi-NTA was added to 1.0910−5 M monoferric transferrins [FeN-hTF () ; FeC-hTF ()] in
10 mM Hepes buffer containing 5 mM bicarbonate at pH 7.4. Δε equals the absorbance at
241 nm divided by the transferrin concentration ; r is the ratio of [Bi] to [hTF]. The titration curve
for hTF/2N () is included for comparison.
citrate (1.36 mM) is required to remove Bi+ from hTF2N
completely. However, for the intact protein Bi

-hTF, such an
excess of citrate appeared to remove only about half of the
bound Bi+ from the protein.
13C-NMR analysis
These experiments were carried out to investigate whether the
binding of Bi+ to hTF2N also involves concomitant binding of
(bi)carbonate as a synergistic anion. Proton-decoupled C-NMR
spectra of a solution containing hTF2N and 10 mM C-
enriched bicarbonate ( 99% in C) in the absence or presence
of Bi+ are shown in Figure 5. In the absence of Bi+, the sharp
signal at 161.1 p.p.m. can be assigned to free bicarbonate, and
the broad envelope at 168–182 p.p.m. to backbone and side
chain carbonyl groups of the protein. After addition of 1.0 molar
equivalent of Bi+ (as Bi-NTA), a new peak at 165.7 p.p.m. is
observed, which can be assigned to bound (bi)carbonate
[13,26,27].
1H-NMR analysis
These experiments were carried out to investigate bismuth-
induced structural changes in hTF2N. Additions of Bi+ were
made (0.6 and 1.0 molar equivalent of [Bi-NTA]) to hTF2N in
the presence of 10 mM bicarbonate. Specific resonances in both
high- and low-field regions of the spectrum progressively dis-
appeared and new resonances appeared, indicative of strong
binding of Bi+ and slow exchange between apo-hTF2N and Bi-
hTF2N on the H-NMR chemical shift time scale. Peaks A, B
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Figure 4 Competition between hTF/2N and citrate for Bi 3+
Changes in molar absorption coefficient at 241 nm of Bi-hTF were monitored with increasing
citrate concentrations at 310 K and pH 7.4. This experiment was carried out by first adding
3.0 molar equivalents of Bi-NTA to hTF/2N to form Bi-hTF/2N, followed by titration with citrate.
Each solution was allowed to equilibrate for 30 min before recording the absorbance. The data
for hTF were obtained under similar conditions.
and C in the high-field region (Figure 6A) gradually decreased in
intensity, and new peaks A, B and C appeared and increased
in intensity on addition of 0.6 and 1.0 molar equivalent of Bi+.
Peaks A (0.602 p.p.m.) and B (0.339 p.p.m.) have previously
been assigned as Ile γ-CH

and Leu δ-CH

respectively, on
the basis of ring-current calculations and with the aid of mutation
of Trp [28,29]. Two-dimensional TOCSY and NOESY
spectra of apo-hTF2N and Bi
.
-hTF2N were also recorded
(results not shown). Analysis of most of the resonances was
impossible due to the large number of overlapping cross-peaks.
However, the two-dimensional spectra are well resolved in the
high-field region. Peaks A (γ-CH

of Ile) and B (δ-CH

of
Leu) had associated cross-peaks at 0.100, 0.400, 0.830 and
1.378 p.p.m., and 0.413, 0.543, 1.143 and 1.457 p.p.m. resp-
ectively, which are consistent with intramolecular nuclear Over-
hauser effects for isoleucine and leucine spin systems. Similar
patterns of cross-peaks for A and A, B and B, and C and C in
the NOESY spectrum of this aliphatic region strongly suggested
that A is the bound form of A, and B and C are the bound
forms of B and C respectively. With 1.0 molar equivalent of Bi+
present, the new resonances increased their intensities further,
while the resonances for hTF2N disappeared almost completely.
Notable shifts induced by Bi+ binding are those for peak A,
0.100 p.p.m. to high-field, peak B, 0.059 p.p.m. to low-field, and
peak C, 0.126 to low-field (Table 1 and Figure 7).
In the histidine C2H region (Figure 8), a notable change is the
appearance of peaks at 7.613 and 7.626 p.p.m. (J). Peaks D, G,
H, and I decreased in intensity, and new peaks K, H, and I also
Figure 5 Carbonate binding to bismuth N-lobe transferrin
13C	1H
-NMR spectra (125 MHz) of (A) hTF/2N (1.8 mM, 80% H2O, 20%
2H2O, pH 7.6) in the
presence of 10 mM NaH13CO3, and (B) with addition of 1.0 molar equivalent of Bi-NTA.
appeared after addition of Bi+. Peaks H and I appeared to
undergo low-field shifts of 0.085 and 0.076 p.p.m. respectively on
addition of 1.0 molar equivalent of Bi+, although again, un-
ambiguous correlations between peaks cannot be made. A sharp
resonance at 5.995 p.p.m., which is sensitive to oxalate and
insensitive to bicarbonate, decreased in intensity and appeared to
shift to 6.004 p.p.m. (broad peak) when 1.0 molar equivalent of
Bi+ was added (results not shown).
Changes were also observed in the region 1.9–2.3 p.p.m.,
which contains resonances for Met-CH

and carbohydrate
(results not shown). Resonances at 2.096, 2.074 and 2.059 p.p.m.
have not been observed previously for hTF2N samples, and are
thus assigned to the two carbohydrate residues that are attached
to the protein in the yeast expression system [17]. The presence
of carbohydrate was also confirmed by the presence of intense
resonances from 3.0 to 4.5 p.p.m. (results not shown). Peaks at
2.218, 2.165, 2.143 and 1.967 p.p.m. have been assigned pre-
viously [30] to S-CH

ofMet, Met	, Met
 andMet	Met

respectively. Upon addition of 0.6 molar equivalent of Bi+, the
broad resonances assigned toMet	Met
 decreased in intensity
and a broad shoulder appeared at 1.982 p.p.m.. On addition of
1.0 molar equivalent of Bi+, the latter peak increased in intensity
further, and that for Met	Met
 disappeared. Similarly, the
Met resonance also disappeared, whereas peaks for Met
 and
those for carbohydrate remained unchanged.
hTF2N was also titrated with the new bismuth anti-ulcer
agent, RBC. This gave rise to NMR spectra identical with those
obtained with Bi-NTA in the presence of 10 mM bicarbonate at
pH* of 7.8 (results not shown), apart from peaks that were due
to added ligands.
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Figure 6 The high-field region of 1H-NMR spectra of hTF/2N and its Bi 3+ and Fe3+ complexes
Resolution-enhanced 500 MHz 1H-NMR spectra are shown of hTF/2N and its Bi3+ and Fe3+ complexes in 10 mM bicarbonate at pH* of 7.8, 310 K : (A) with addition of 0 (bottom), 0.6 (middle)
and 1.0 (top) molar equivalents of Bi-NTA ; and (B) with addition of 0 (bottom), 0.5 (middle) and 0.9 (top) molar equivalents of [Fe(NTA)2].
Table 1 Chemical shifts (δ) for 1H-NMR resonances of hTF/2N and its
metal complexes
Connectivities were obtained from double-quantum-filtered COSY, TOCSY and NOESY, and
assignments are on the basis of previous work [18,28]. For peaks ’ labels, see Figure 6. Ox,
oxalate ; CO3, carbonate.
Leu122 Ile132
Protein B B1 B2 A C
hTF/2N 0.333 0.418 0.542 0.605 0.173
ox-hTF/2N 0.343 0.412 0.548 0.617 0.166
Ga-ox-hTF/2N 0.308 0.299 0.567 0.897 0.044
Δδ (Ga)* 0.035 0.113 0.019 0.28 0.122
hTF/2N 0.335 0.601 0.178
CO3-hTF/2N 0.335 0.589 0.173
Ga-CO3-hTF/2N 0.413 0.846 0.014
Δδ (Ga)* 0.078 0.257 0.159
CO3-hTF/2N† 0.333 0.635 0.110
Al-CO3-hTF/2N 0.401 0.839 0.042
Δδ (Al)* 0.068 0.204 0.068
CO3-hTF/2N‡ 0.339 0.603 0.178
Fe-CO3-hTF/2N 0.378 0.825 0.081
Δδ (Fe)* 0.039 0.222 0.097
CO3-hTF/2N‡ 0.339 0.413 0.543 0.603 0.170
Bi-CO3-hTF/2N 0.280 0.359 0.561 0.703 0.044
Δδ (Bi)* 0.059 0.054 0.018 0.100 0.126
*Co-ordination shift ; †pH* at 8.8 ; ‡pH* 7.80 ; for these data, hTF/2N was expressed in
the methylotrophic yeast P. pastoris and contained two carbohydrate residues that are not
present in the N-lobe of the intact serum protein [17].
In order to compare H chemical shifts induced by Bi+ with
those induced by Fe+, a titration of hTF2N with Fe+ [added
as Fe(NTA)

] in the presence of 10 mM bicarbonate at pH* 7.8
Figure 7 Stack plot illustrating the changes in shifts of the high-field
resonances after metal binding
See text for details.
was also carried out. Although H-NMR spectra were broadened
upon addition of Fe+, owing to the paramagnetic effects
of bound high-spin Fe+, new peaks in the high-field (Figure
6B) and methionine regions were still observable. The chemical
shifts induced by Fe+ appeared to be almost identical with
those induced by Bi+ in these regions, indicative of a similar
binding mode and similar structural changes. Notable co-
ordination shifts induced by Fe+ complexation are those of
peak A (Ile), 0.222 p.p.m. to high field, peak B (Leu),
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Figure 8 Effect of Bi3+ and bicarbonate on the aromatic region (His region)
of the 500 MHz 1H-NMR spectra of transferrin N-lobe
hTF/2N (bottom) ; addition of 10 mM bicarbonate to hTF/2N (lower middle) ; and subsequent
additions of 0.6 (upper middle) and 1.0 mol (top) equivalents of Bi-NTA.
0.039 p.p.m. to high field, and peak C, 0.097 p.p.m. to low field
(Table 1 and Figure 7). In the histidine C2H region, peaks at I
(8.052 p.p.m.), H (7.920 p.p.m.) and D (7.682 p.p.m.) became
significantly broadened on addition of 0.5 molar equivalent of
Fe+, and disappeared almost completely after addition of slightly
less than 1.0 molar equivalent of Fe+ (to avoid excess of non-
protein-bound Fe+).
DISCUSSION
Bi+ [ionic radius 1.03 A (0.103 nm)] is a much larger ion than
Fe+ [radius 0.65 A (0.065 nm), high-spin state], but binds to
human transferrin almost as strongly as Fe+, a feature which can
be correlated with its high acidity (low pK
a
of bound H

O) [24].
In the present work we have determined the binding constant
for Bi+ binding to hTF2N, log K* [25] of 18.90.2. Thus Bi+
binds to the N-lobe almost as strongly as to the intact protein
(log K

* 19.4, log K

* 18.6 [13]). This appears to be the first
determination of a binding constant for any metal ion for the
isolated N-lobe.
The larger stability constant for Bi+ binding to hTF can be
associated with Bi+ uptake by the C-lobe, since this lobe has
been shown by two-dimensional H- and C-NMR studies of
Met-ε-C-labelled protein to take up Bi+ preferentially [21].
Other metal ions, such as Fe+, Zn+ and Sm+, also show
preferential binding to the C-lobe, although Ni+ and Al+, under
certain conditions, are taken up preferentially by the N-lobe of
hTF [18,31]. The specificity of uptake can be influenced by the
initial ligand complexed to the metal ion, the synergistic anion
and the pH. Since the transferrin receptor binds much more
strongly to transferrin loaded with two Fe+ ions, it is interesting
to examine possible communication between the N- and C-lobes.
In this work, we have investigated the effect of Fe+ loading of
the N- or C-lobe on the binding of Bi+ to the other lobe. With
Fe+ in the N-lobe of hTF (Fe
N
-hTF), Bi+ binds to the C-lobe as
strongly as it does in the apoprotein (N-lobe vacant), whereas the
binding of Bi+ to the N-lobe of hTF with Fe+ in the C-lobe
(Fe
C
-hTF) is much weaker than binding to the isolated N-lobe.
Calorimetric studies of the binding of Fe+ to ovotransferrin
have shown that binding to one lobe is communicated to the
other [32], and C-NMR studies have suggested that Ga+
binding to the N-lobe is communicated to the C-lobe [30].
Previous reports have shown that Al+, Zn+, Nd+ and Sm+ also
have a higher affinity for the C-lobe compared with the N-lobe
[33–35].
Since a large excess of citrate is required to remove significant
amounts of Bi+ from transferrin (Figure 4), it seems likely that
citrate would not be a major competitor for Bi+ in blood plasma
(citrate concentration 100 μM [36] ; hTF:citrate ratio approx.
1:3). Comparison of the curves in Figure 4 suggests that citrate
is much less effective in removing Bi+ from the C-lobe compared
with the N-lobe. In blood, hTF is normally saturated to a level
of only  30% with Fe+, which occupies the N-lobe [16],
although it has been suggested that this switch from C- to N-lobe
preference may be related to the presence of receptor protein [37].
In general, the H-NMR spectrum of hTF2N consists of a
large number of broad overlapping resonances. However, reason-
able assignments have been proposed previously for several
peaks in the high-field region, specifically for Leu and Ile,
which are above and below Trp in the hydrophobic patch of
helix 5. This helix makes contact with the anion and metal-
binding site via its N-terminal end. Therefore these resonances
are sensitive to metal binding (Figure 6A) and the shift changes
may arise from small movements of the side chains of Leu and
Ile relative to that of Trp. On titration of hTF2N with Bi+
these peaks showNMRshifts characteristic of slowBi+ exchange
(on the NMR time scale), indicative of strong Bi+ binding. As
can be seen from Figure 7, the shift changes for these resonances
induced by Ga+, Al+ and Bi+ are all of the same sign and
similar in magnitude, suggesting that all the metal ions induce
a similar conformational change in this part of the protein.
Interestingly, the sign of the shift change for Leu (Figure 7)
with Bi+ is opposite to that with Ga+, Al+ and Fe+, although
similar to that seen for Ga+ with oxalate as synergistic anion.
Therefore this may be a consequence of both the large size of Bi+
(ionic radius 1.03 A ) compared with Ga+ (0.62 A ), Al+ (0.54 A )
or Fe+ (0.65 A ), and the large size of oxalate compared with
carbonate. We have shown previously [29] that oxalate binding
causes shifts of the hTF2N resonance at 5.995 p.p.m. No such
shifts were observed in this work with bicarbonate as the
synergistic anion, which may be indicative of a different binding
mode or affinity for these two anions before addition of metal.
The shift changes for the Met-S-ε-CH

resonances of hTF2N
111N-lobe versus C-lobe complexation of bismuth by transferrin
on Bi+ binding are similar to those observed previously [29] for
Ga+. The methionine residues are well dispersed in the protein’s
structure, and their behaviour is probably a good indication of
the similar binding mode of these metal ions. In view of this it
will be interesting to investigate the binding of Bi+-transferrin to
the transferrin receptor. Such work is in progress.
Our studies show that Bi+ in the form of the anti-ulcer drug,
RBC, is also readily transferred to hTf2N, forming the same
transferrin adducts as for Bi-NTA. Citrate is readily displaced
from Bi+ by hTF2N and could act as a transfer agent in blood
plasma. Further experiments on blood plasma are required to
establish whether this is the case.
Conclusion
We have made the first determination of a stability constant for
metal binding to recombinant N-lobe of human transferrin.
The metal ion used, Bi+, is important because it forms the basis
of widely used anti-ulcer drugs. Bi+ binds strongly to hTF2N
(log K* 18.90.2 in 5 mM bicarbonate10 mM Hepes buffer
at 310 K, pH 7.4). The presence of bound synergistic anion
(CO

−) was confirmed by C- and H-NMR studies, and
suggested that the conformational changes induced by Bi+
binding are similar to those induced by Fe+, Al+ and Ga+.
Studies on hTF suggested that occupation of the C-lobe by Fe+
perturbs Bi+ binding to the N-lobe, but Fe+ occupation of the
N-lobe has little effect on Bi+ binding to the C-lobe. Future
work will focus on an investigation of the biological activity of
bismuth transferrin.
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